ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced four strategic additions to its executive leadership team: Jeff ...

Protein Biomarkers May Play an Important Role in Overcoming Limitations of Circulating Tumor DNA for Screening Early-Stage ...

New research on 175,000 women—the largest NHS study to date—on the use of AI in breast cancer screening shows that AI ...

Market has emerged as a rapidly expanding segment within the oncology diagnostics and liquid biopsy landscape. Circulating ...

Her German shepherd saved her life by detecting cancer in its earliest stage–and now an E-nose can detect tumors with AI chemical training.

Affinity leans on its CyPath Lung sputum test for early lung cancer detection, while Guardant Health expands liquid biopsy and screening. Which strategy is ahead? Let's see.

Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

As healthcare systems worldwide grapple with rising cancer rates, chronic diseases and limited clinical resources, ...

Tommy Cannon shares prostate cancer update with fans and urges men to get tested - The comedian also recalled a particularly ...

Discover how innovative start-ups are revolutionising patient care in Singapore, from stroke recovery to early cancer detection. Read more at straitstimes.com. Read more at straitstimes.com.

New research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early liver fibrosis & cirrhosis and may signal broader chronic disease burden.

Researchers at the European Molecular Biology Laboratory (EMBL) in Germany have unveiled an artificial intelligence system designed to ...